Skip to main content
. 2009 Jul 6;5(1):23. doi: 10.2202/1557-4679.1152

Figure 6:

Figure 6:

A plot of estimated average slope and concavity coefficients for fluoxetine (20 mg) treated responders (solid points) and non-responders (open points). The vertical line is the placebo-group average slope discriminant (PGASD) criterion boundary.